The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
Abstract
Histopathological reports of multiple sclerosis and its animal models have shown evidence of a link between axonal injury in active lesions and impaired glutamate metabolism. Mature oligodendrocytes play a role in glutamate uptake to maintain glutamate homeostasis but in multiple sclerosis white matter the loss of expression of glutamate transporters in the lesion vicinity results in ineffective glutamate removal. Using a magnetic resonance spectroscopy technique that isolates the glutamate resonance at 3 T, we compared glutamate levels between normal subjects and multiple sclerosis patients in different brain areas. Metabolite concentrations (glutamate, glutamine, N-acetyl-aspartate, myo-inositol, choline, creatine) were derived from LCmodel and corrected for T1 relaxation time. Glutamate concentrations were found to be elevated in acute lesions (P = 0.02) and normal-appearing white matter (P = 0.03), with no significant elevation in chronic lesions (P = 0.77). The N-acetyl-aspartate level in chronic lesions was significantly lower (P < 0.001) than in acute lesions and normal-appearing white matter. The choline level in acute lesions was significantly higher (P < 0.001) than in chronic lesions. Evidence was also found for increased glial activity in multiple sclerosis, with significantly higher (P < 0.001) myo-inositol levels in acute lesions compared with control white matter. These in vivo results support the hypothesis that altered glutamate metabolism is present in brains of multiple sclerosis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Estimation of metabolite concentrations from localized in vivo proton NMR spectra
Provencher, S. W. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300604 · Cited by 3,655
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
Tietz Textbook of Clinical Chemistry
(1999) · Archives of Pathology and Laboratory Medicine · doi:10.5858/123.7.646b · Cited by 2,495
Localization of neuronal and glial glutamate transporters
Rothstein, J. D., Martin, L., Levey, A. I., Dykes-Hoberg, M., Jin, L., Wu, D., Nash, N., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,702
Multinuclear NMR Studies on the Energy Metabolism of Glial and Neuronal Cells
Brand, A., Richter-Landsberg, C., & Leibfritz, D. (1993) · Developmental Neuroscience · doi:10.1159/000111347 · Cited by 884
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
The Role of Excitotoxicity in Neurodegenerative Disease
Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723
Computer Simulations in Magnetic Resonance. An Object-Oriented Programming Approach
Smith, S. A., Levante, T. O., Meier, B. H., & Ernst, R. R. (1994) · Journal of Magnetic Resonance, Series A · doi:10.1006/jmra.1994.1008 · Cited by 710
Glutamine, glutamate and gaba in the central nervous system
Teelken, A. W. (1986) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(86)90020-x · Cited by 672
Monocyte/macrophage differentiation in early multiple sclerosis lesions
Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmarch, H. A., & Lassmann, H. (1995) · Annals of Neurology · doi:10.1002/ana.410380514 · Cited by 530
Werner, P., Pitt, D., & Raine, C. S. (2001) · Annals of Neurology · doi:10.1002/ana.1077 · Cited by 486
Imaging axonal damage of normal-appearing white matter in multiple sclerosis
Fu, L. (1998) · Brain · doi:10.1093/brain/121.1.103 · Cited by 481
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467
A neuron–glia signalling network in the active brain
Bezzi, P., & Volterra, A. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00223-3 · Cited by 446
Prineas, J. W., & Rg, W. (1978) · PubMed · Cited by 417
Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
Piani, D., Frei, K., Do, K. Q., Cuénod, M., & Fontana, A. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90559-c · Cited by 416
Narayana, P. A., Doyle, T. J., Lai, D., & Wolinsky, J. S. (1998) · Annals of Neurology · doi:10.1002/ana.410430112 · Cited by 318
Traugott, U., Reinherz, E. L., & Raine, C. S. (1983) · Journal of Neuroimmunology · doi:10.1016/0165-5728(83)90036-x · Cited by 315
Proton T1 and T2 relaxation times of human brain metabolites at 3 Tesla
Mlynárik, V., Gruber, S., & Moser, E. (2001) · NMR in Biomedicine · doi:10.1002/nbm.713 · Cited by 296
(2001) · PubMed Central · Cited by 289
Schubert, F., Gallinat, J., Seifert, F., & Rinneberg, H. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.11.014 · Cited by 282
Chard, D. T. (2002) · Brain · doi:10.1093/brain/awf240 · Cited by 280
Measurement of brain glutamate using TE‐averaged PRESS at 3T
Hurd, R., Sailasuta, N., Srinivasan, R., Vigneron, D. B., Pelletier, D., & Nelson, S. J. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20007 · Cited by 238
Self-citationGlutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
Pitt, D., Nagelmeier, I. E., Wilson, H. C., & Raine, C. S. (2003) · Neurology · doi:10.1212/01.wnl.0000090564.88719.37 · Cited by 222
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis
Fernando, K. T. M. (2004) · Brain · doi:10.1093/brain/awh153 · Cited by 222
Ethofer, T., Mader, I., Seeger, U., Helms, G., Erb, M., Grodd, W., Ludolph, A., & Klose, U. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10640 · Cited by 211
Pathological abnormalities in the normal-appearing white matter in multiple sclerosis
Allen, I. V., McQuaid, S., Mirakhur, M., & Nevin, G. (2001) · Neurological Sciences · doi:10.1007/s100720170012 · Cited by 198
Rothstein, J. D. (1996) · Neurology · doi:10.1212/wnl.47.4_suppl_2.19s · Cited by 174
Glutamate and Glutamine Metabolism and Compartmentation in Astrocytes
Schousboe, A., Westergaard, N., Sonnewald, U., Petersen, S. B., Huang, R., Peng, L., & Hertz, L. (1993) · Developmental Neuroscience · doi:10.1159/000111356 · Cited by 173
Fast Removal of Synaptic Glutamate by Postsynaptic Transporters
Auger, C., & Attwell, D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00132-x · Cited by 172
Sarchielli, P., Presciutti, O., Pelliccioli, G. P., Tarducci, R., Gobbi, G., Chiarini, P., Alberti, A., Vicinanza, F., & Gallai, V. (1999) · Brain · doi:10.1093/brain/122.3.513 · Cited by 160
A Wallerian degeneration pattern in patients at risk for MS
Simon, J. H., Kinkel, R. P., Jacobs, L., Bub, L., & Simonian, N. A. (2000) · Neurology · doi:10.1212/wnl.54.5.1155 · Cited by 142
Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer’s disease
Hattori, N., Abe, K., Sakoda, S., & Sawada, T. (2002) · Neuroreport · doi:10.1097/00001756-200201210-00041 · Cited by 112
Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema.
Barnes, D., McDonald, W. I., Johnson, G., Tofts, P. S., & LANDON, D. N. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.2.125 · Cited by 98
Mader, I., Roser, W., Kappos, L., Hagberg, G. E., Seelig, J., Radue, E. W., & Steinbrich, W. (2000) · PubMed Central · Cited by 87
Pan, J. W., Mason, G. F., Pohost, G. M., & Hetherington, H. P. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910360103 · Cited by 77
Helms, G. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1186 · Cited by 65
Distribution of Glial Fibrillary Acidic Protein in Gliosed Human White Matter
Newcombe, J., Woodroofe, M. N., & Cuzner, M. L. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13079.x · Cited by 64
Is the myelin membrane abnormal in multiple sclerosis?
Wood, D. D., & Moscarello, M. A. (1984) · The Journal of Membrane Biology · doi:10.1007/bf01871058 · Cited by 37
Waldvogel (1999) · doi:10.1002/1531-8249(199907)46:1
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Cited by
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Dutta, R., & Trapp, B. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.005 · Cited by 457
Centonze, D., Muzio, L., Rossi, S., Cavasinni, F., De Chiara, V., Bergami, A., Musella, A., D'Amelio, M., Cavallucci, V., Martorana, A., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5804-08.2009 · Cited by 390
Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement
Beart, P. M., & O'Shea, R. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706949 · Cited by 377
Metadata
- Authors
- Srinivasan, R., Sailasuta, N., Hurd, R., Nelson, S., & Pelletier, D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-09
- Volume
- 128
- Issue
- 5
- Pages
- 1016-1025
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2082688434
- Cited by
- 465
- References
- 42
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.